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Education and debate
Genetics, race, ethnicity, and health
Neil Pearce, Sunia Foliaki, Andrew Sporle, Chris Cunningham
Genetics plays only a small part in ethnic differences in health, and other factors are often more
amenable to change
In the past few decades spectacular advances have
occurred in molecular biology techniques. Researchers
have been eager to use these new techniques to study
ethnic or racial differences in health that are
commonly assumed to have genetic causes. We argue
that this assumption is based on confusion between
three very different concepts: genetics, race, and
ethnicity. This is invalid both scientifically and in terms
of public health policy. We concentrate on research in
Maori and Pacific (Polynesian) people, but the issues
considered are of more general relevance.
Genotypes and phenotypes
It is a common misconception that the genotype
determines the phenotype. Genetic factors do have a
large influence on health, but they are just one piece of
a much larger picture. We are all continuously
developing throughout our lives with a constant inter-
action between our genes and the environment.1 Any
discussion of genetic tendencies thus makes assump-
tions about who is normal and what is a normal envi-
ronment.2 For example, some researchers have argued
that Polynesians have a thrifty genotype with a greater
tendency towards obesity and non-communicable dis-
eases such as diabetes when they adopt a European
diet.3 It now seems, however, that almost everyone
except Europeans may have the thrifty genotype.4
Genetics, heritability, and the environment
The constant interaction between genes and the
environment means that few diseases are purely
hereditary (even if they are genetic). Purely hereditary
diseases are very rare (1/2300 births for cystic fibrosis,
1/3000 for Duchenne’s muscular dystrophy, and
1/10 000 for Huntington’s disease) and account for a
small proportion of overall disease.2
It is often assumed that diseases are genetic
because they run in families, but this often reflects a
common environment and lifestyle rather than a
genetic influence. For example, in 1900 the Pellagra
Commission investigated the problem of pellagra (a
vitamin deficiency disease) in the southern United
States and concluded that it was genetic because it ran
in families; “apparently, no one on the Commission
realized that poverty and malnutrition run in families
too.”5 In fact, the characteristic that is most strongly
inherited is religion.2
Even for classic genetic diseases, environmental
factors usually also have an important role and are
easier to modify.6 This may change with the continuing
development of techniques such as gene therapy, but
to date it has promised much and delivered little.7 In
fact, genetic studies can show the importance of
environmental factors. Mendelian randomisation
means that rare genetic polymorphisms that mimic
common environmental factors (such as low dietary
folate intake) can be studied epidemiologically to
establish the causal associations of these environmen-
tal factors with disease (such as neural tube defects).8
Race
So what does this have to do with race? The term race
has been commonly defined in terms of biological dif-
ferences between groups that are assumed to be
genetic. For example, Risch et al argued that five major
racial groups can be identified (Africans, Caucasians,
Pacific Islanders, Asians, and Native Americans).9
However, human races are not and never were pure,10
and such broad continental groupings explain little in
terms of the overall genetic variation of humanity. For
example, Lewontin2 writes that:
Skin colour, hair form, and nose shape are certainly
influenced by genes, but we do not know how many such
genes there are, or how they work. On the other hand . . .
Environmental factors have more influence on health than genetic
differences
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about 85 percent of all identified human genetic variation is
between any two individuals from the same ethnic group.
Another 8 percent of all the variation is between ethnic
groups within a race—say, between Spaniards, Irish, Italians,
and Britons—and only 7 percent of all human genetic varia-
tion lies on the average between major human races such as
those of Africa, Asia, Europe, and Oceania.
This is not to say that there are no genetic differences
between races, but very few differences have been found
which directly relate to health.7 Those that have been
shown are usually not absolute; rather, they concern dif-
ferences in the percentage of people that have particular
gene types. Furthermore, most known genetic variants
that are health related are random mutations in
subpopulations or result from regional selection and are
not related to continental race.7
Race and health
A New Zealand study of alcoholism provides one
example of a health related genetic difference.11 The
authors found that the ADH2-2 gene, which is believed
to protect against alcoholism, was relatively common
in Maori people but was not found in New Zealand
Europeans. In fact, alcohol related health problems are
more common in Maori, suggesting that the hypoth-
esised protective genetic factors are being outweighed
by social, economic, cultural, and political factors.
Further evidence that genetic factors are unlikely to
explain racial differences in health is provided by trends
in death rates. Maori death rates fell steeply in the last
century, although the rate of progress has slowed in the
last two decades.12 Major problems remain, but the
rapid reduction in many of these diseases strongly
suggests that they are not primarily genetic.
Ethnicity and health
The fact that racial categorisation based on genetic cri-
teria is inaccurate and misleading13 does not change
the historical reality of the effects of colonisation on
indigenous peoples, nor the realities of indigenous
health today. It does, however, change our interpreta-
tion of the causes of high mortality and morbidity in
indigenous peoples, which primarily relate to issues of
ethnicity, rather than of race or genetics.
Ethnicity is a complex construct that includes biol-
ogy, history, cultural orientation and practice,14
language, religion, and lifestyle, all of which can affect
health. The lack of major systematic genetic differences
between ethnic groups, together with the extensive dif-
ferences in lifestyle (diet, alcohol, housing, smoking,
etc), means that ethnic differences in mortality and
morbidity to some extent provide evidence against the
importance of genetic factors and for the importance
of environmental factors.
For example, the European colonisation of the
Pacific and the Americas after 1492 saw indigenous
populations decimated by imported communicable
diseases.15 In the Pacific, indigenous people experi-
enced high mortality from imported infectious
diseases mainly when their land was taken, disrupting
their economic base, food supply, and social networks.
When land was not taken in large amounts by
European settlers, the death rate was relatively low.15
Similar effects of social disruption resulting in
increased mortality have been seen more recently in
Eastern Europe and again in the Pacific.15 16
Ethnic differences in access to health care
Access to health care is also important for ethnic
differences in health. For example, the high death rates
from asthma in Maori people in the 1980s led some
researchers to assume that Maori have a genetic
tendency to asthma. However, the high death rate was
primarily due to the drug fenoterol, which affected
Maori people particularly severely. This is probably
because problems accessing health care meant that
Maori people were more likely to overuse the drug.17
When fenoterol was restricted in 1989, the asthma
death rate fell sharply and is now low in both Maori
and non-Maori populations.17 Furthermore, until
recently the prevalence of asthma was about the same
in Maori and non-Maori children, but non-Maori chil-
dren tended to lose the disease as they grew older
whereas Maori children did not, producing a greater
prevalence in adult Maori.18 This is probably due to
poor access to health care and asthma education.18
Similar considerations may apply to other diseases
requiring long term medical management, such as dia-
betes and cardiovascular disease. Ibrahim and col-
leagues recently argued that issues of access to care
include a complex mix of cultural factors and
individual preferences of patients, characteristics, and
practices of healthcare professionals (such as racism,
stereotyping, bias, discrimination, and lack of cultural
safety), and the system of delivery of health care (such
as composition of the workforce, location of facilities,
costs of access, and involvement of different ethnic
groups in shaping health policy and allocation of
resources).19 They argued that “racial and ethnic
disparities in health and health care are rooted in his-
toric socioeconomic inequalities that persist . . . today.”
Thus race may be important in terms of the
perceptions of healthcare workers, rather than in terms
of the underlying disease aetiology.
Gene hunting: the new research
colonialism
Genetic research will undoubtedly lead to important
discoveries and new forms of treatment. However, such
Summary points
The concepts of genetics, race, and ethnicity are commonly confused
Genetic factors are important for health but are a small part of a
large and complex picture
Few systematic genetic differences exist between races, at least with
regard to genes that affect health
Ethnic differences in health are due to historical, cultural, and
socioeconomic factors, which in turn influence lifestyle and access to
health care.
Overemphasis on genetic explanations may divert attention and
resources from more important influences on health
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benefits are a long way off and require large investments
with potential benefits for a few high risk individuals
(and researchers). This leaves little to promote the health
of the majority. The emphasis on genetic explanations
for population differences in health has also led to con-
troversial instances of “gene hunting” by multinational
institutions.20 The affected countries may have inad-
equate or non-existing legislation on ethical and social
protection for human subjects of health research in
general, or genetic research in particular. The wave of
health research that has swept the Pacific since the late
1960s has turned the “Pacific into a laboratory for exotic
researchers.”20 In response, it has been argued that there
must be a strong community base for health research
that is of community relevance, with a sustained
community involvement in research planning and
implementation.15
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Q&A
Effects of ginkgo extract
Question
What are the benefits and side effects of Ginkgo biloba? Does it
cause high blood pressure?
Mahmood M Althahabi, pilot, Bahrain
Answer
The dried leaf of the ginkgo tree has been used in medicine for
thousands of years. More than 400 studies over the past 30 years
have investigated its ability to improve blood flow in a variety of
conditions including memory impairment, dementia, peripheral
vascular diseases, and tinnitus. The results have shown modest
improvements, not to some remarkable levels. The results much
depend on the patient’s psychological framework.
In general, it is well tolerated. Allergic skin reactions,
gastrointestinal upsets, and headaches occur in fewer than 2% of
patients. There are theoretical concerns about a risk of increased
bleeding because of inhibition of platelet activating factor.
Although no bleeding complications have been reported in any
clinical trials, caution should be exercised when taking ginkgo
with aspirin, warfarin, or other anticoagulant. No effects on blood
pressure have been documented.
Ali K Yousuf, senior house officer, Karachi, Pakistan
Answer
Ginkgo biloba is said to have neutral effects on blood pressure.
However, there are reports suggesting that it may have
antihypertensive actions.
In a study on healthy, young volunteers, ginkgo in a dose of
120 mg given twice daily for seven days was not found to have
any immediate or short term effects on systolic or diastolic blood
pressure.1 In a randomised, double blind trial a significant
decrease in diastolic blood pressure was reported in elderly
patients with age related cognitive dysfunction who were given an
extract of ginkgo (GB-8) for three months.2 In one study on
healthy volunteers, a single treatment with an extract of ginkgo
(EGb 761, 120 mg) was found to reduce stress induced rise in
blood pressure without affecting the heart rate.3
Vikas Soni, medical advisor, Ahmadabad, India
1 Kalus JS, Piotrowski AA, Fortier CR, Liu X, Kluger J, White CM. Hemodynamic
and electrocardiographic effects of short-term Ginkgo biloba. Ann Pharmacother
2003;37:345-9.
2 Winther K, Randløv C, Rein E, Mehlsen J. Effects of Ginkgo biloba extract on
cognitive function and blood pressure in elderly subjects. Curr Ther Res
1998;59:881-8.
3 Jezova D, Duncko R, Lassanova M, Kriska M, Moncek F. Reduction of rise in blood
pressure and cortisol release during stress by Ginkgo biloba extract (EGb 761) in
healthy volunteers. J Physiol Pharmacol 2002;53:337-48.
Answer
I started taking gingko before exams as it had been suggested
that it helped memory, and I have noticed that, since starting it,
I have not had a migraine. This is, of course, a purely anecdotal
benefit, but it worked for me.
Beth Bain, specialist trainee in public health,West Midlands Specialised
Services Agency
http://bmj.com/cgi/qa-display/short/bmj_el;46670
These exchanges were posted on the Q&A section of bmj.com. If you want
to respond to the question, or ask a new question of your own, follow the
link above or go to http://bmj.com/q&a
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